Muscle phosphoglycerate mutase deficiency revisited

Ali Naini, Antonio Toscano, Olimpia Musumeci, John Vissing, Hasan O. Akman, Salvatore DiMauro

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background: Phosphoglycerate mutase (PGAM) deficiency (glycogen storage disease type X) has been reported in 12 patients of whom 9 were African American. Objective: To describe 2 patients, 1 of Pakistani and 1 of Italian ethnic origin, with typical clinical and biochemical changes of glycogen storage disease type X and novel mutations in the gene encoding the muscle subunit of PGAM (PGAM2). Design: Clinical, pathological, biochemical, and molecular analyses. Setting: Tertiary care university hospitals and academic institutions. Patients: A 37-year-old Danish man of Pakistani origin who had exercise-related cramps and myoglobinuria and a 65-year-old Italian man who had exercise intolerance and myalgia but no pigmenturia and had undergone long-term statin therapy. Main Outcome Measures: Clinical course and biochemical and molecular features. Results: Biochemical evidence showed severe isolated PGAM deficiency, and molecular studies revealed 2 novel homozygous mutations, a nonsense mutation and a single nucleotide deletion. Pathological studies of muscle showed mild glycogen accumulation but prominent tubular aggregates in both patients. Conclusions: We found that glycogen storage disease type X is not confined to the African American population, is often associated with sarcoplasmic reticulum (SR) proliferation, and is genetically heterogeneous.

Original languageEnglish
Pages (from-to)394-398
Number of pages5
JournalArchives of Neurology
Volume66
Issue number3
DOIs
Publication statusPublished - Mar 2009

Fingerprint

Muscles
African Americans
Phosphoglycerate Mutase
Myoglobinuria
Exercise
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Muscle Cramp
Mutation
Nonsense Codon
Myalgia
Sarcoplasmic Reticulum
Tertiary Healthcare
Glycogen
Nucleotides
Outcome Assessment (Health Care)
Dimauro disease
Population
Genes
Therapeutics
Gene

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Naini, A., Toscano, A., Musumeci, O., Vissing, J., Akman, H. O., & DiMauro, S. (2009). Muscle phosphoglycerate mutase deficiency revisited. Archives of Neurology, 66(3), 394-398. https://doi.org/10.1001/archneurol.2008.584

Muscle phosphoglycerate mutase deficiency revisited. / Naini, Ali; Toscano, Antonio; Musumeci, Olimpia; Vissing, John; Akman, Hasan O.; DiMauro, Salvatore.

In: Archives of Neurology, Vol. 66, No. 3, 03.2009, p. 394-398.

Research output: Contribution to journalArticle

Naini, A, Toscano, A, Musumeci, O, Vissing, J, Akman, HO & DiMauro, S 2009, 'Muscle phosphoglycerate mutase deficiency revisited', Archives of Neurology, vol. 66, no. 3, pp. 394-398. https://doi.org/10.1001/archneurol.2008.584
Naini A, Toscano A, Musumeci O, Vissing J, Akman HO, DiMauro S. Muscle phosphoglycerate mutase deficiency revisited. Archives of Neurology. 2009 Mar;66(3):394-398. https://doi.org/10.1001/archneurol.2008.584
Naini, Ali ; Toscano, Antonio ; Musumeci, Olimpia ; Vissing, John ; Akman, Hasan O. ; DiMauro, Salvatore. / Muscle phosphoglycerate mutase deficiency revisited. In: Archives of Neurology. 2009 ; Vol. 66, No. 3. pp. 394-398.
@article{170e6263385940eabfd038b67f50ee76,
title = "Muscle phosphoglycerate mutase deficiency revisited",
abstract = "Background: Phosphoglycerate mutase (PGAM) deficiency (glycogen storage disease type X) has been reported in 12 patients of whom 9 were African American. Objective: To describe 2 patients, 1 of Pakistani and 1 of Italian ethnic origin, with typical clinical and biochemical changes of glycogen storage disease type X and novel mutations in the gene encoding the muscle subunit of PGAM (PGAM2). Design: Clinical, pathological, biochemical, and molecular analyses. Setting: Tertiary care university hospitals and academic institutions. Patients: A 37-year-old Danish man of Pakistani origin who had exercise-related cramps and myoglobinuria and a 65-year-old Italian man who had exercise intolerance and myalgia but no pigmenturia and had undergone long-term statin therapy. Main Outcome Measures: Clinical course and biochemical and molecular features. Results: Biochemical evidence showed severe isolated PGAM deficiency, and molecular studies revealed 2 novel homozygous mutations, a nonsense mutation and a single nucleotide deletion. Pathological studies of muscle showed mild glycogen accumulation but prominent tubular aggregates in both patients. Conclusions: We found that glycogen storage disease type X is not confined to the African American population, is often associated with sarcoplasmic reticulum (SR) proliferation, and is genetically heterogeneous.",
author = "Ali Naini and Antonio Toscano and Olimpia Musumeci and John Vissing and Akman, {Hasan O.} and Salvatore DiMauro",
year = "2009",
month = "3",
doi = "10.1001/archneurol.2008.584",
language = "English",
volume = "66",
pages = "394--398",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Muscle phosphoglycerate mutase deficiency revisited

AU - Naini, Ali

AU - Toscano, Antonio

AU - Musumeci, Olimpia

AU - Vissing, John

AU - Akman, Hasan O.

AU - DiMauro, Salvatore

PY - 2009/3

Y1 - 2009/3

N2 - Background: Phosphoglycerate mutase (PGAM) deficiency (glycogen storage disease type X) has been reported in 12 patients of whom 9 were African American. Objective: To describe 2 patients, 1 of Pakistani and 1 of Italian ethnic origin, with typical clinical and biochemical changes of glycogen storage disease type X and novel mutations in the gene encoding the muscle subunit of PGAM (PGAM2). Design: Clinical, pathological, biochemical, and molecular analyses. Setting: Tertiary care university hospitals and academic institutions. Patients: A 37-year-old Danish man of Pakistani origin who had exercise-related cramps and myoglobinuria and a 65-year-old Italian man who had exercise intolerance and myalgia but no pigmenturia and had undergone long-term statin therapy. Main Outcome Measures: Clinical course and biochemical and molecular features. Results: Biochemical evidence showed severe isolated PGAM deficiency, and molecular studies revealed 2 novel homozygous mutations, a nonsense mutation and a single nucleotide deletion. Pathological studies of muscle showed mild glycogen accumulation but prominent tubular aggregates in both patients. Conclusions: We found that glycogen storage disease type X is not confined to the African American population, is often associated with sarcoplasmic reticulum (SR) proliferation, and is genetically heterogeneous.

AB - Background: Phosphoglycerate mutase (PGAM) deficiency (glycogen storage disease type X) has been reported in 12 patients of whom 9 were African American. Objective: To describe 2 patients, 1 of Pakistani and 1 of Italian ethnic origin, with typical clinical and biochemical changes of glycogen storage disease type X and novel mutations in the gene encoding the muscle subunit of PGAM (PGAM2). Design: Clinical, pathological, biochemical, and molecular analyses. Setting: Tertiary care university hospitals and academic institutions. Patients: A 37-year-old Danish man of Pakistani origin who had exercise-related cramps and myoglobinuria and a 65-year-old Italian man who had exercise intolerance and myalgia but no pigmenturia and had undergone long-term statin therapy. Main Outcome Measures: Clinical course and biochemical and molecular features. Results: Biochemical evidence showed severe isolated PGAM deficiency, and molecular studies revealed 2 novel homozygous mutations, a nonsense mutation and a single nucleotide deletion. Pathological studies of muscle showed mild glycogen accumulation but prominent tubular aggregates in both patients. Conclusions: We found that glycogen storage disease type X is not confined to the African American population, is often associated with sarcoplasmic reticulum (SR) proliferation, and is genetically heterogeneous.

UR - http://www.scopus.com/inward/record.url?scp=62449173194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62449173194&partnerID=8YFLogxK

U2 - 10.1001/archneurol.2008.584

DO - 10.1001/archneurol.2008.584

M3 - Article

C2 - 19273759

AN - SCOPUS:62449173194

VL - 66

SP - 394

EP - 398

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 3

ER -